nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP2C9—Trimethadione—epilepsy syndrome	0.0499	0.105	CbGbCtD
Agomelatine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0469	0.0983	CbGbCtD
Agomelatine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0374	0.0784	CbGbCtD
Agomelatine—CYP1A2—Primidone—epilepsy syndrome	0.0349	0.0732	CbGbCtD
Agomelatine—CYP2C9—Carbamazepine—epilepsy syndrome	0.0337	0.0706	CbGbCtD
Agomelatine—CYP2C9—Primidone—epilepsy syndrome	0.0315	0.0659	CbGbCtD
Agomelatine—CYP1A2—Propofol—epilepsy syndrome	0.0313	0.0656	CbGbCtD
Agomelatine—CYP2C9—Phenytoin—epilepsy syndrome	0.0302	0.0633	CbGbCtD
Agomelatine—CYP1A2—Phenobarbital—epilepsy syndrome	0.0299	0.0627	CbGbCtD
Agomelatine—CYP1A2—Diazepam—epilepsy syndrome	0.0283	0.0594	CbGbCtD
Agomelatine—CYP2C9—Propofol—epilepsy syndrome	0.0282	0.0591	CbGbCtD
Agomelatine—CYP2C9—Phenobarbital—epilepsy syndrome	0.0269	0.0565	CbGbCtD
Agomelatine—CYP2C9—Diazepam—epilepsy syndrome	0.0255	0.0535	CbGbCtD
Agomelatine—CYP1A2—Valproic Acid—epilepsy syndrome	0.0223	0.0468	CbGbCtD
Agomelatine—CYP2C9—Valproic Acid—epilepsy syndrome	0.0201	0.0422	CbGbCtD
Agomelatine—MTNR1A—forebrain—epilepsy syndrome	0.00529	0.113	CbGeAlD
Agomelatine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00496	0.106	CbGeAlD
Agomelatine—MTNR1A—telencephalon—epilepsy syndrome	0.00486	0.104	CbGeAlD
Agomelatine—MTNR1B—head—epilepsy syndrome	0.00383	0.0818	CbGeAlD
Agomelatine—HTR2C—ganglion—epilepsy syndrome	0.00309	0.0659	CbGeAlD
Agomelatine—MTNR1A—head—epilepsy syndrome	0.00303	0.0647	CbGeAlD
Agomelatine—MTNR1A—nervous system—epilepsy syndrome	0.00287	0.0613	CbGeAlD
Agomelatine—MTNR1A—central nervous system—epilepsy syndrome	0.00276	0.059	CbGeAlD
Agomelatine—MTNR1A—brain—epilepsy syndrome	0.00219	0.0469	CbGeAlD
Agomelatine—HTR2C—brainstem—epilepsy syndrome	0.00134	0.0287	CbGeAlD
Agomelatine—HTR2C—forebrain—epilepsy syndrome	0.0013	0.0277	CbGeAlD
Agomelatine—HTR2B—forebrain—epilepsy syndrome	0.00122	0.026	CbGeAlD
Agomelatine—HTR2C—telencephalon—epilepsy syndrome	0.00119	0.0254	CbGeAlD
Agomelatine—HTR2B—telencephalon—epilepsy syndrome	0.00112	0.0239	CbGeAlD
Agomelatine—Naproxen—SLCO1A2—epilepsy syndrome	0.00102	0.197	CrCbGaD
Agomelatine—HTR2C—medulla oblongata—epilepsy syndrome	0.000936	0.02	CbGeAlD
Agomelatine—HTR2C—midbrain—epilepsy syndrome	0.000855	0.0183	CbGeAlD
Agomelatine—HTR2C—spinal cord—epilepsy syndrome	0.000834	0.0178	CbGeAlD
Agomelatine—Indomethacin—SLCO1A2—epilepsy syndrome	0.000826	0.159	CrCbGaD
Agomelatine—HTR2C—head—epilepsy syndrome	0.000742	0.0158	CbGeAlD
Agomelatine—HTR2C—nervous system—epilepsy syndrome	0.000703	0.015	CbGeAlD
Agomelatine—HTR2B—head—epilepsy syndrome	0.000697	0.0149	CbGeAlD
Agomelatine—HTR2C—central nervous system—epilepsy syndrome	0.000677	0.0145	CbGeAlD
Agomelatine—HTR2B—nervous system—epilepsy syndrome	0.00066	0.0141	CbGeAlD
Agomelatine—HTR2B—central nervous system—epilepsy syndrome	0.000636	0.0136	CbGeAlD
Agomelatine—Midodrine—CYP2D6—epilepsy syndrome	0.000557	0.108	CrCbGaD
Agomelatine—HTR2C—brain—epilepsy syndrome	0.000537	0.0115	CbGeAlD
Agomelatine—HTR2B—brain—epilepsy syndrome	0.000505	0.0108	CbGeAlD
Agomelatine—Encainide—CYP2D6—epilepsy syndrome	0.000496	0.0958	CrCbGaD
Agomelatine—Nabumetone—PTGS2—epilepsy syndrome	0.000456	0.088	CrCbGaD
Agomelatine—Indomethacin—ABCC2—epilepsy syndrome	0.000395	0.0762	CrCbGaD
Agomelatine—Melatonin—CYP2C19—epilepsy syndrome	0.000291	0.0563	CrCbGaD
Agomelatine—Indomethacin—CYP2C19—epilepsy syndrome	0.000274	0.053	CrCbGaD
Agomelatine—Naproxen—PTGS2—epilepsy syndrome	0.000211	0.0407	CrCbGaD
Agomelatine—Somnolence—Carbamazepine—epilepsy syndrome	0.000205	0.000715	CcSEcCtD
Agomelatine—Urticaria—Felbamate—epilepsy syndrome	0.000205	0.000715	CcSEcCtD
Agomelatine—Vision blurred—Valproic Acid—epilepsy syndrome	0.000205	0.000714	CcSEcCtD
Agomelatine—Abdominal pain—Felbamate—epilepsy syndrome	0.000204	0.000711	CcSEcCtD
Agomelatine—Vomiting—Acetazolamide—epilepsy syndrome	0.000204	0.000711	CcSEcCtD
Agomelatine—Diarrhoea—Propofol—epilepsy syndrome	0.000204	0.000711	CcSEcCtD
Agomelatine—Pruritus—Levetiracetam—epilepsy syndrome	0.000204	0.00071	CcSEcCtD
Agomelatine—Tremor—Valproic Acid—epilepsy syndrome	0.000203	0.000709	CcSEcCtD
Agomelatine—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000203	0.000709	CcSEcCtD
Agomelatine—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000203	0.000708	CcSEcCtD
Agomelatine—Insomnia—Lamotrigine—epilepsy syndrome	0.000202	0.000703	CcSEcCtD
Agomelatine—Headache—Acetazolamide—epilepsy syndrome	0.000201	0.000701	CcSEcCtD
Agomelatine—Urticaria—Zonisamide—epilepsy syndrome	0.000201	0.0007	CcSEcCtD
Agomelatine—Paraesthesia—Lamotrigine—epilepsy syndrome	0.0002	0.000698	CcSEcCtD
Agomelatine—Abdominal pain—Zonisamide—epilepsy syndrome	0.0002	0.000696	CcSEcCtD
Agomelatine—Agitation—Valproic Acid—epilepsy syndrome	0.0002	0.000696	CcSEcCtD
Agomelatine—Asthenia—Fosphenytoin—epilepsy syndrome	0.000199	0.000695	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000199	0.000695	CcSEcCtD
Agomelatine—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000199	0.000694	CcSEcCtD
Agomelatine—Fatigue—Carbamazepine—epilepsy syndrome	0.000199	0.000694	CcSEcCtD
Agomelatine—Angioedema—Valproic Acid—epilepsy syndrome	0.000198	0.000692	CcSEcCtD
Agomelatine—Somnolence—Lamotrigine—epilepsy syndrome	0.000198	0.000691	CcSEcCtD
Agomelatine—Weight increased—Topiramate—epilepsy syndrome	0.000198	0.00069	CcSEcCtD
Agomelatine—Mental disorder—Pregabalin—epilepsy syndrome	0.000198	0.000689	CcSEcCtD
Agomelatine—Constipation—Carbamazepine—epilepsy syndrome	0.000197	0.000688	CcSEcCtD
Agomelatine—Dizziness—Propofol—epilepsy syndrome	0.000197	0.000687	CcSEcCtD
Agomelatine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000197	0.000687	CcSEcCtD
Agomelatine—Weight decreased—Topiramate—epilepsy syndrome	0.000197	0.000686	CcSEcCtD
Agomelatine—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000197	0.000686	CcSEcCtD
Agomelatine—Pruritus—Fosphenytoin—epilepsy syndrome	0.000196	0.000685	CcSEcCtD
Agomelatine—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000196	0.000685	CcSEcCtD
Agomelatine—Vertigo—Valproic Acid—epilepsy syndrome	0.000195	0.00068	CcSEcCtD
Agomelatine—Asthenia—Vigabatrin—epilepsy syndrome	0.000194	0.000677	CcSEcCtD
Agomelatine—Infestation—Topiramate—epilepsy syndrome	0.000194	0.000676	CcSEcCtD
Agomelatine—Infestation NOS—Topiramate—epilepsy syndrome	0.000194	0.000676	CcSEcCtD
Agomelatine—Urticaria—Clonazepam—epilepsy syndrome	0.000193	0.000674	CcSEcCtD
Agomelatine—Eye disorder—Gabapentin—epilepsy syndrome	0.000193	0.000674	CcSEcCtD
Agomelatine—Depression—Topiramate—epilepsy syndrome	0.000193	0.000674	CcSEcCtD
Agomelatine—Tinnitus—Gabapentin—epilepsy syndrome	0.000193	0.000672	CcSEcCtD
Agomelatine—Dizziness—Midazolam—epilepsy syndrome	0.000193	0.000672	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000192	0.000671	CcSEcCtD
Agomelatine—Abdominal pain—Clonazepam—epilepsy syndrome	0.000192	0.000671	CcSEcCtD
Agomelatine—Fatigue—Lamotrigine—epilepsy syndrome	0.000192	0.00067	CcSEcCtD
Agomelatine—Urticaria—Phenytoin—epilepsy syndrome	0.000192	0.00067	CcSEcCtD
Agomelatine—Pruritus—Vigabatrin—epilepsy syndrome	0.000192	0.000668	CcSEcCtD
Agomelatine—Asthenia—Diazepam—epilepsy syndrome	0.000191	0.000667	CcSEcCtD
Agomelatine—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000191	0.000666	CcSEcCtD
Agomelatine—Constipation—Lamotrigine—epilepsy syndrome	0.000191	0.000665	CcSEcCtD
Agomelatine—Nausea—Acetazolamide—epilepsy syndrome	0.00019	0.000664	CcSEcCtD
Agomelatine—Dizziness—Levetiracetam—epilepsy syndrome	0.00019	0.000664	CcSEcCtD
Agomelatine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.00019	0.000663	CcSEcCtD
Agomelatine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00019	0.000663	CcSEcCtD
Agomelatine—Back pain—Pregabalin—epilepsy syndrome	0.00019	0.000662	CcSEcCtD
Agomelatine—Vomiting—Propofol—epilepsy syndrome	0.000189	0.00066	CcSEcCtD
Agomelatine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000189	0.000658	CcSEcCtD
Agomelatine—Pruritus—Diazepam—epilepsy syndrome	0.000189	0.000658	CcSEcCtD
Agomelatine—Naproxen—ALB—epilepsy syndrome	0.000188	0.0363	CrCbGaD
Agomelatine—Headache—Propofol—epilepsy syndrome	0.000187	0.000651	CcSEcCtD
Agomelatine—Vomiting—Midazolam—epilepsy syndrome	0.000185	0.000646	CcSEcCtD
Agomelatine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000185	0.000646	CcSEcCtD
Agomelatine—Asthenia—Felbamate—epilepsy syndrome	0.000185	0.000645	CcSEcCtD
Agomelatine—Vision blurred—Pregabalin—epilepsy syndrome	0.000185	0.000645	CcSEcCtD
Agomelatine—Anxiety—Valproic Acid—epilepsy syndrome	0.000184	0.000642	CcSEcCtD
Agomelatine—Tremor—Pregabalin—epilepsy syndrome	0.000184	0.000641	CcSEcCtD
Agomelatine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000184	0.00064	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000184	0.00064	CcSEcCtD
Agomelatine—Urticaria—Carbamazepine—epilepsy syndrome	0.000183	0.000639	CcSEcCtD
Agomelatine—Vomiting—Levetiracetam—epilepsy syndrome	0.000183	0.000638	CcSEcCtD
Agomelatine—Headache—Midazolam—epilepsy syndrome	0.000183	0.000637	CcSEcCtD
Agomelatine—Pruritus—Felbamate—epilepsy syndrome	0.000182	0.000636	CcSEcCtD
Agomelatine—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000182	0.000636	CcSEcCtD
Agomelatine—Diarrhoea—Diazepam—epilepsy syndrome	0.000182	0.000636	CcSEcCtD
Agomelatine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000182	0.000636	CcSEcCtD
Agomelatine—Asthenia—Zonisamide—epilepsy syndrome	0.000181	0.000632	CcSEcCtD
Agomelatine—Mental disorder—Gabapentin—epilepsy syndrome	0.000181	0.000632	CcSEcCtD
Agomelatine—Dry mouth—Valproic Acid—epilepsy syndrome	0.000181	0.00063	CcSEcCtD
Agomelatine—Agitation—Pregabalin—epilepsy syndrome	0.00018	0.000629	CcSEcCtD
Agomelatine—Headache—Levetiracetam—epilepsy syndrome	0.00018	0.000629	CcSEcCtD
Agomelatine—Angioedema—Pregabalin—epilepsy syndrome	0.000179	0.000625	CcSEcCtD
Agomelatine—Dizziness—Vigabatrin—epilepsy syndrome	0.000179	0.000624	CcSEcCtD
Agomelatine—Pruritus—Zonisamide—epilepsy syndrome	0.000179	0.000623	CcSEcCtD
Agomelatine—Urticaria—Lamotrigine—epilepsy syndrome	0.000177	0.000618	CcSEcCtD
Agomelatine—Nausea—Propofol—epilepsy syndrome	0.000177	0.000617	CcSEcCtD
Agomelatine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000177	0.000616	CcSEcCtD
Agomelatine—Diarrhoea—Felbamate—epilepsy syndrome	0.000176	0.000615	CcSEcCtD
Agomelatine—Vertigo—Pregabalin—epilepsy syndrome	0.000176	0.000615	CcSEcCtD
Agomelatine—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000176	0.000615	CcSEcCtD
Agomelatine—Dizziness—Diazepam—epilepsy syndrome	0.000176	0.000615	CcSEcCtD
Agomelatine—Infection—Valproic Acid—epilepsy syndrome	0.000176	0.000614	CcSEcCtD
Agomelatine—Asthenia—Clonazepam—epilepsy syndrome	0.000175	0.000609	CcSEcCtD
Agomelatine—Back pain—Gabapentin—epilepsy syndrome	0.000174	0.000607	CcSEcCtD
Agomelatine—Headache—Fosphenytoin—epilepsy syndrome	0.000174	0.000607	CcSEcCtD
Agomelatine—Hepatitis—Topiramate—epilepsy syndrome	0.000174	0.000607	CcSEcCtD
Agomelatine—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000174	0.000606	CcSEcCtD
Agomelatine—Asthenia—Phenytoin—epilepsy syndrome	0.000173	0.000605	CcSEcCtD
Agomelatine—Nausea—Midazolam—epilepsy syndrome	0.000173	0.000604	CcSEcCtD
Agomelatine—Hallucination—Topiramate—epilepsy syndrome	0.000173	0.000604	CcSEcCtD
Agomelatine—Diarrhoea—Zonisamide—epilepsy syndrome	0.000173	0.000602	CcSEcCtD
Agomelatine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000172	0.000602	CcSEcCtD
Agomelatine—Pruritus—Clonazepam—epilepsy syndrome	0.000172	0.0006	CcSEcCtD
Agomelatine—Vomiting—Vigabatrin—epilepsy syndrome	0.000172	0.0006	CcSEcCtD
Agomelatine—Skin disorder—Valproic Acid—epilepsy syndrome	0.000172	0.0006	CcSEcCtD
Agomelatine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000171	0.000597	CcSEcCtD
Agomelatine—Pruritus—Phenytoin—epilepsy syndrome	0.000171	0.000596	CcSEcCtD
Agomelatine—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000171	0.000596	CcSEcCtD
Agomelatine—Nausea—Levetiracetam—epilepsy syndrome	0.000171	0.000596	CcSEcCtD
Agomelatine—Indomethacin—PTGS2—epilepsy syndrome	0.000171	0.033	CrCbGaD
Agomelatine—Dizziness—Felbamate—epilepsy syndrome	0.000171	0.000595	CcSEcCtD
Agomelatine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00017	0.000593	CcSEcCtD
Agomelatine—Vision blurred—Gabapentin—epilepsy syndrome	0.00017	0.000592	CcSEcCtD
Agomelatine—Headache—Vigabatrin—epilepsy syndrome	0.00017	0.000591	CcSEcCtD
Agomelatine—Vomiting—Diazepam—epilepsy syndrome	0.000169	0.000591	CcSEcCtD
Agomelatine—Tremor—Gabapentin—epilepsy syndrome	0.000169	0.000588	CcSEcCtD
Agomelatine—Dizziness—Zonisamide—epilepsy syndrome	0.000167	0.000582	CcSEcCtD
Agomelatine—Headache—Diazepam—epilepsy syndrome	0.000167	0.000582	CcSEcCtD
Agomelatine—Anxiety—Pregabalin—epilepsy syndrome	0.000167	0.000581	CcSEcCtD
Agomelatine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000166	0.000581	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000166	0.000579	CcSEcCtD
Agomelatine—Asthenia—Carbamazepine—epilepsy syndrome	0.000166	0.000577	CcSEcCtD
Agomelatine—Agitation—Gabapentin—epilepsy syndrome	0.000165	0.000577	CcSEcCtD
Agomelatine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000165	0.000577	CcSEcCtD
Agomelatine—Nausea—Fosphenytoin—epilepsy syndrome	0.000165	0.000575	CcSEcCtD
Agomelatine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000164	0.000574	CcSEcCtD
Agomelatine—Angioedema—Gabapentin—epilepsy syndrome	0.000164	0.000574	CcSEcCtD
Agomelatine—Vomiting—Felbamate—epilepsy syndrome	0.000164	0.000572	CcSEcCtD
Agomelatine—Dry mouth—Pregabalin—epilepsy syndrome	0.000163	0.00057	CcSEcCtD
Agomelatine—Pruritus—Carbamazepine—epilepsy syndrome	0.000163	0.000569	CcSEcCtD
Agomelatine—Eye disorder—Topiramate—epilepsy syndrome	0.000163	0.000567	CcSEcCtD
Agomelatine—Tinnitus—Topiramate—epilepsy syndrome	0.000162	0.000566	CcSEcCtD
Agomelatine—Vertigo—Gabapentin—epilepsy syndrome	0.000162	0.000564	CcSEcCtD
Agomelatine—Headache—Felbamate—epilepsy syndrome	0.000162	0.000564	CcSEcCtD
Agomelatine—Dizziness—Clonazepam—epilepsy syndrome	0.000161	0.000561	CcSEcCtD
Agomelatine—Nausea—Vigabatrin—epilepsy syndrome	0.000161	0.000561	CcSEcCtD
Agomelatine—Vomiting—Zonisamide—epilepsy syndrome	0.000161	0.00056	CcSEcCtD
Agomelatine—Insomnia—Valproic Acid—epilepsy syndrome	0.00016	0.000559	CcSEcCtD
Agomelatine—Asthenia—Lamotrigine—epilepsy syndrome	0.00016	0.000558	CcSEcCtD
Agomelatine—Dizziness—Phenytoin—epilepsy syndrome	0.00016	0.000557	CcSEcCtD
Agomelatine—Infection—Pregabalin—epilepsy syndrome	0.000159	0.000555	CcSEcCtD
Agomelatine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000159	0.000555	CcSEcCtD
Agomelatine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000159	0.000554	CcSEcCtD
Agomelatine—Nausea—Diazepam—epilepsy syndrome	0.000158	0.000552	CcSEcCtD
Agomelatine—Headache—Zonisamide—epilepsy syndrome	0.000158	0.000552	CcSEcCtD
Agomelatine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000158	0.000551	CcSEcCtD
Agomelatine—Pruritus—Lamotrigine—epilepsy syndrome	0.000158	0.00055	CcSEcCtD
Agomelatine—Somnolence—Valproic Acid—epilepsy syndrome	0.000158	0.000549	CcSEcCtD
Agomelatine—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000157	0.000548	CcSEcCtD
Agomelatine—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000156	0.000544	CcSEcCtD
Agomelatine—Skin disorder—Pregabalin—epilepsy syndrome	0.000156	0.000543	CcSEcCtD
Agomelatine—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000155	0.00054	CcSEcCtD
Agomelatine—Vomiting—Clonazepam—epilepsy syndrome	0.000155	0.00054	CcSEcCtD
Agomelatine—Vomiting—Phenytoin—epilepsy syndrome	0.000154	0.000536	CcSEcCtD
Agomelatine—Nausea—Felbamate—epilepsy syndrome	0.000153	0.000534	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000153	0.000533	CcSEcCtD
Agomelatine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000153	0.000533	CcSEcCtD
Agomelatine—Fatigue—Valproic Acid—epilepsy syndrome	0.000153	0.000533	CcSEcCtD
Agomelatine—Anxiety—Gabapentin—epilepsy syndrome	0.000153	0.000533	CcSEcCtD
Agomelatine—Dizziness—Carbamazepine—epilepsy syndrome	0.000153	0.000532	CcSEcCtD
Agomelatine—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000153	0.000532	CcSEcCtD
Agomelatine—Headache—Clonazepam—epilepsy syndrome	0.000152	0.000532	CcSEcCtD
Agomelatine—Mental disorder—Topiramate—epilepsy syndrome	0.000152	0.000531	CcSEcCtD
Agomelatine—Indomethacin—ALB—epilepsy syndrome	0.000152	0.0294	CrCbGaD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000152	0.000531	CcSEcCtD
Agomelatine—Constipation—Valproic Acid—epilepsy syndrome	0.000152	0.000528	CcSEcCtD
Agomelatine—Headache—Phenytoin—epilepsy syndrome	0.000151	0.000528	CcSEcCtD
Agomelatine—Headache—Oxcarbazepine—epilepsy syndrome	0.000151	0.000525	CcSEcCtD
Agomelatine—Nausea—Zonisamide—epilepsy syndrome	0.00015	0.000523	CcSEcCtD
Agomelatine—Dry mouth—Gabapentin—epilepsy syndrome	0.00015	0.000523	CcSEcCtD
Agomelatine—Dizziness—Lamotrigine—epilepsy syndrome	0.000147	0.000514	CcSEcCtD
Agomelatine—Vomiting—Carbamazepine—epilepsy syndrome	0.000147	0.000512	CcSEcCtD
Agomelatine—Back pain—Topiramate—epilepsy syndrome	0.000146	0.000511	CcSEcCtD
Agomelatine—Infection—Gabapentin—epilepsy syndrome	0.000146	0.000509	CcSEcCtD
Agomelatine—Indomethacin—ABCB1—epilepsy syndrome	0.000145	0.028	CrCbGaD
Agomelatine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000145	0.000505	CcSEcCtD
Agomelatine—Insomnia—Pregabalin—epilepsy syndrome	0.000145	0.000505	CcSEcCtD
Agomelatine—Nausea—Clonazepam—epilepsy syndrome	0.000145	0.000504	CcSEcCtD
Agomelatine—Headache—Carbamazepine—epilepsy syndrome	0.000145	0.000504	CcSEcCtD
Agomelatine—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000144	0.000502	CcSEcCtD
Agomelatine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000144	0.000502	CcSEcCtD
Agomelatine—Nausea—Phenytoin—epilepsy syndrome	0.000144	0.000501	CcSEcCtD
Agomelatine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000143	0.000498	CcSEcCtD
Agomelatine—Vision blurred—Topiramate—epilepsy syndrome	0.000143	0.000498	CcSEcCtD
Agomelatine—Skin disorder—Gabapentin—epilepsy syndrome	0.000143	0.000498	CcSEcCtD
Agomelatine—Somnolence—Pregabalin—epilepsy syndrome	0.000142	0.000497	CcSEcCtD
Agomelatine—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000142	0.000495	CcSEcCtD
Agomelatine—Tremor—Topiramate—epilepsy syndrome	0.000142	0.000495	CcSEcCtD
Agomelatine—Vomiting—Lamotrigine—epilepsy syndrome	0.000142	0.000494	CcSEcCtD
Agomelatine—Urticaria—Valproic Acid—epilepsy syndrome	0.000141	0.000491	CcSEcCtD
Agomelatine—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00014	0.000488	CcSEcCtD
Agomelatine—Headache—Lamotrigine—epilepsy syndrome	0.00014	0.000487	CcSEcCtD
Agomelatine—Agitation—Topiramate—epilepsy syndrome	0.000139	0.000485	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000138	0.000482	CcSEcCtD
Agomelatine—Fatigue—Pregabalin—epilepsy syndrome	0.000138	0.000482	CcSEcCtD
Agomelatine—Nausea—Carbamazepine—epilepsy syndrome	0.000137	0.000478	CcSEcCtD
Agomelatine—Constipation—Pregabalin—epilepsy syndrome	0.000137	0.000478	CcSEcCtD
Agomelatine—Vertigo—Topiramate—epilepsy syndrome	0.000136	0.000474	CcSEcCtD
Agomelatine—Insomnia—Gabapentin—epilepsy syndrome	0.000133	0.000463	CcSEcCtD
Agomelatine—Nausea—Lamotrigine—epilepsy syndrome	0.000132	0.000462	CcSEcCtD
Agomelatine—Paraesthesia—Gabapentin—epilepsy syndrome	0.000132	0.00046	CcSEcCtD
Agomelatine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000131	0.000457	CcSEcCtD
Agomelatine—Somnolence—Gabapentin—epilepsy syndrome	0.000131	0.000455	CcSEcCtD
Agomelatine—Dyspepsia—Gabapentin—epilepsy syndrome	0.000129	0.000451	CcSEcCtD
Agomelatine—Anxiety—Topiramate—epilepsy syndrome	0.000128	0.000448	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000128	0.000446	CcSEcCtD
Agomelatine—Urticaria—Pregabalin—epilepsy syndrome	0.000127	0.000444	CcSEcCtD
Agomelatine—Asthenia—Valproic Acid—epilepsy syndrome	0.000127	0.000443	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000127	0.000442	CcSEcCtD
Agomelatine—Fatigue—Gabapentin—epilepsy syndrome	0.000127	0.000442	CcSEcCtD
Agomelatine—Abdominal pain—Pregabalin—epilepsy syndrome	0.000127	0.000442	CcSEcCtD
Agomelatine—Dry mouth—Topiramate—epilepsy syndrome	0.000126	0.00044	CcSEcCtD
Agomelatine—Constipation—Gabapentin—epilepsy syndrome	0.000126	0.000438	CcSEcCtD
Agomelatine—Pruritus—Valproic Acid—epilepsy syndrome	0.000125	0.000437	CcSEcCtD
Agomelatine—Infection—Topiramate—epilepsy syndrome	0.000123	0.000428	CcSEcCtD
Agomelatine—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000121	0.000423	CcSEcCtD
Agomelatine—Nervous system disorder—Topiramate—epilepsy syndrome	0.000121	0.000423	CcSEcCtD
Agomelatine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00012	0.000419	CcSEcCtD
Agomelatine—Skin disorder—Topiramate—epilepsy syndrome	0.00012	0.000419	CcSEcCtD
Agomelatine—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000119	0.000417	CcSEcCtD
Agomelatine—Dizziness—Valproic Acid—epilepsy syndrome	0.000117	0.000409	CcSEcCtD
Agomelatine—Urticaria—Gabapentin—epilepsy syndrome	0.000117	0.000407	CcSEcCtD
Agomelatine—Abdominal pain—Gabapentin—epilepsy syndrome	0.000116	0.000405	CcSEcCtD
Agomelatine—Asthenia—Pregabalin—epilepsy syndrome	0.000115	0.000401	CcSEcCtD
Agomelatine—Pruritus—Pregabalin—epilepsy syndrome	0.000113	0.000395	CcSEcCtD
Agomelatine—Vomiting—Valproic Acid—epilepsy syndrome	0.000113	0.000393	CcSEcCtD
Agomelatine—Insomnia—Topiramate—epilepsy syndrome	0.000112	0.00039	CcSEcCtD
Agomelatine—Headache—Valproic Acid—epilepsy syndrome	0.000111	0.000387	CcSEcCtD
Agomelatine—Paraesthesia—Topiramate—epilepsy syndrome	0.000111	0.000387	CcSEcCtD
Agomelatine—Somnolence—Topiramate—epilepsy syndrome	0.00011	0.000383	CcSEcCtD
Agomelatine—Diarrhoea—Pregabalin—epilepsy syndrome	0.00011	0.000382	CcSEcCtD
Agomelatine—Dyspepsia—Topiramate—epilepsy syndrome	0.000109	0.000379	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000107	0.000372	CcSEcCtD
Agomelatine—Fatigue—Topiramate—epilepsy syndrome	0.000107	0.000372	CcSEcCtD
Agomelatine—Dizziness—Pregabalin—epilepsy syndrome	0.000106	0.000369	CcSEcCtD
Agomelatine—Constipation—Topiramate—epilepsy syndrome	0.000106	0.000369	CcSEcCtD
Agomelatine—Asthenia—Gabapentin—epilepsy syndrome	0.000105	0.000368	CcSEcCtD
Agomelatine—Nausea—Valproic Acid—epilepsy syndrome	0.000105	0.000367	CcSEcCtD
Agomelatine—Pruritus—Gabapentin—epilepsy syndrome	0.000104	0.000362	CcSEcCtD
Agomelatine—Vomiting—Pregabalin—epilepsy syndrome	0.000102	0.000355	CcSEcCtD
Agomelatine—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000101	0.000352	CcSEcCtD
Agomelatine—Diarrhoea—Gabapentin—epilepsy syndrome	0.0001	0.000351	CcSEcCtD
Agomelatine—Headache—Pregabalin—epilepsy syndrome	0.0001	0.00035	CcSEcCtD
Agomelatine—Urticaria—Topiramate—epilepsy syndrome	9.82e-05	0.000342	CcSEcCtD
Agomelatine—Abdominal pain—Topiramate—epilepsy syndrome	9.77e-05	0.000341	CcSEcCtD
Agomelatine—Dizziness—Gabapentin—epilepsy syndrome	9.71e-05	0.000339	CcSEcCtD
Agomelatine—Nausea—Pregabalin—epilepsy syndrome	9.51e-05	0.000332	CcSEcCtD
Agomelatine—Vomiting—Gabapentin—epilepsy syndrome	9.34e-05	0.000326	CcSEcCtD
Agomelatine—Headache—Gabapentin—epilepsy syndrome	9.2e-05	0.000321	CcSEcCtD
Agomelatine—Asthenia—Topiramate—epilepsy syndrome	8.87e-05	0.000309	CcSEcCtD
Agomelatine—Pruritus—Topiramate—epilepsy syndrome	8.74e-05	0.000305	CcSEcCtD
Agomelatine—Nausea—Gabapentin—epilepsy syndrome	8.72e-05	0.000304	CcSEcCtD
Agomelatine—Diarrhoea—Topiramate—epilepsy syndrome	8.45e-05	0.000295	CcSEcCtD
Agomelatine—Dizziness—Topiramate—epilepsy syndrome	8.17e-05	0.000285	CcSEcCtD
Agomelatine—Vomiting—Topiramate—epilepsy syndrome	7.86e-05	0.000274	CcSEcCtD
Agomelatine—Headache—Topiramate—epilepsy syndrome	7.74e-05	0.00027	CcSEcCtD
Agomelatine—Nausea—Topiramate—epilepsy syndrome	7.34e-05	0.000256	CcSEcCtD
Agomelatine—HTR2B—Signaling Pathways—ATP2A2—epilepsy syndrome	1.58e-05	8.61e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.58e-05	8.58e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AVP—epilepsy syndrome	1.58e-05	8.57e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—JUN—epilepsy syndrome	1.55e-05	8.43e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—JUN—epilepsy syndrome	1.55e-05	8.43e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CX3CR1—epilepsy syndrome	1.54e-05	8.39e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGT—epilepsy syndrome	1.54e-05	8.38e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.53e-05	8.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.53e-05	8.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.53e-05	8.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.53e-05	8.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.53e-05	8.33e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CRH—epilepsy syndrome	1.53e-05	8.31e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—OXT—epilepsy syndrome	1.53e-05	8.31e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL2—epilepsy syndrome	1.53e-05	8.31e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL3—epilepsy syndrome	1.53e-05	8.31e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HSPB1—epilepsy syndrome	1.53e-05	8.31e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.52e-05	8.29e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.52e-05	8.29e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BDKRB1—epilepsy syndrome	1.51e-05	8.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CHRM2—epilepsy syndrome	1.51e-05	8.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CX3CL1—epilepsy syndrome	1.51e-05	8.22e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-05	8.2e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-05	8.2e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR5—epilepsy syndrome	1.51e-05	8.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.5e-05	8.14e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.49e-05	8.1e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.49e-05	8.09e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CDC42—epilepsy syndrome	1.48e-05	8.03e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2A—epilepsy syndrome	1.48e-05	8.02e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GABBR1—epilepsy syndrome	1.47e-05	8e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.46e-05	7.96e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.46e-05	7.96e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.43e-05	7.79e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AVP—epilepsy syndrome	1.43e-05	7.78e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.43e-05	7.75e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TSC1—epilepsy syndrome	1.42e-05	7.73e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTK2B—epilepsy syndrome	1.42e-05	7.73e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HRH3—epilepsy syndrome	1.41e-05	7.67e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.4e-05	7.62e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.4e-05	7.62e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.4e-05	7.62e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGT—epilepsy syndrome	1.4e-05	7.61e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.39e-05	7.58e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SRC—epilepsy syndrome	1.39e-05	7.56e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SRC—epilepsy syndrome	1.39e-05	7.56e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—OPRM1—epilepsy syndrome	1.39e-05	7.55e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR2—epilepsy syndrome	1.38e-05	7.52e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK2—epilepsy syndrome	1.38e-05	7.52e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SST—epilepsy syndrome	1.38e-05	7.52e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DUSP6—epilepsy syndrome	1.37e-05	7.45e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.36e-05	7.38e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.36e-05	7.38e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-05	7.37e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-05	7.37e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.35e-05	7.35e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.35e-05	7.33e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PLAT—epilepsy syndrome	1.35e-05	7.32e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR5—epilepsy syndrome	1.34e-05	7.28e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR3—epilepsy syndrome	1.31e-05	7.13e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.31e-05	7.13e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.3e-05	7.08e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.3e-05	7.08e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.3e-05	7.07e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL12—epilepsy syndrome	1.3e-05	7.07e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—POMC—epilepsy syndrome	1.3e-05	7.06e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.3e-05	7.04e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.3e-05	7.04e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.29e-05	7.03e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.29e-05	7.01e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NPY—epilepsy syndrome	1.28e-05	6.95e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ATP2A2—epilepsy syndrome	1.28e-05	6.95e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—JUNB—epilepsy syndrome	1.28e-05	6.94e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CNR1—epilepsy syndrome	1.28e-05	6.94e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.27e-05	6.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PLCB1—epilepsy syndrome	1.27e-05	6.91e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.27e-05	6.89e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR7—epilepsy syndrome	1.25e-05	6.77e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGT—epilepsy syndrome	1.24e-05	6.76e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.24e-05	6.75e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—OXT—epilepsy syndrome	1.23e-05	6.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL2—epilepsy syndrome	1.23e-05	6.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CRH—epilepsy syndrome	1.23e-05	6.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL3—epilepsy syndrome	1.23e-05	6.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HSPB1—epilepsy syndrome	1.23e-05	6.7e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.22e-05	6.66e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.22e-05	6.62e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR5—epilepsy syndrome	1.22e-05	6.61e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HBEGF—epilepsy syndrome	1.21e-05	6.57e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.2e-05	6.5e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.19e-05	6.48e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR2A—epilepsy syndrome	1.19e-05	6.47e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT3—epilepsy syndrome	1.19e-05	6.45e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—POMC—epilepsy syndrome	1.18e-05	6.41e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.16e-05	6.31e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.16e-05	6.31e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADAM10—epilepsy syndrome	1.16e-05	6.3e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL2—epilepsy syndrome	1.15e-05	6.27e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.15e-05	6.25e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TSC1—epilepsy syndrome	1.15e-05	6.23e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTK2B—epilepsy syndrome	1.15e-05	6.23e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGT—epilepsy syndrome	1.13e-05	6.14e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.12e-05	6.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK2—epilepsy syndrome	1.12e-05	6.06e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SST—epilepsy syndrome	1.12e-05	6.06e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR2—epilepsy syndrome	1.12e-05	6.06e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.11e-05	6.02e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.11e-05	6.02e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DUSP6—epilepsy syndrome	1.11e-05	6.01e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—S100B—epilepsy syndrome	1.1e-05	5.96e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRA2A—epilepsy syndrome	1.09e-05	5.93e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PLAT—epilepsy syndrome	1.09e-05	5.91e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.09e-05	5.9e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SOCS3—epilepsy syndrome	1.09e-05	5.9e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.08e-05	5.89e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDC42—epilepsy syndrome	1.08e-05	5.88e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.06e-05	5.77e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BDKRB2—epilepsy syndrome	1.05e-05	5.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL12—epilepsy syndrome	1.05e-05	5.7e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AVP—epilepsy syndrome	1.05e-05	5.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—POMC—epilepsy syndrome	1.05e-05	5.69e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PRKCB—epilepsy syndrome	1.04e-05	5.67e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.04e-05	5.67e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.04e-05	5.66e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6ST—epilepsy syndrome	1.04e-05	5.65e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CNR1—epilepsy syndrome	1.03e-05	5.6e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—JUNB—epilepsy syndrome	1.03e-05	5.6e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PLCB1—epilepsy syndrome	1.03e-05	5.58e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.02e-05	5.56e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR7—epilepsy syndrome	1e-05	5.46e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HES1—epilepsy syndrome	9.91e-06	5.39e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	9.82e-06	5.34e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	9.82e-06	5.34e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HBEGF—epilepsy syndrome	9.75e-06	5.3e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FYN—epilepsy syndrome	9.64e-06	5.24e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—H2AFX—epilepsy syndrome	9.6e-06	5.22e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MEF2C—epilepsy syndrome	9.58e-06	5.21e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT3—epilepsy syndrome	9.57e-06	5.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	9.56e-06	5.2e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—POMC—epilepsy syndrome	9.51e-06	5.17e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADAM10—epilepsy syndrome	9.35e-06	5.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL2—epilepsy syndrome	9.31e-06	5.06e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	9.28e-06	5.04e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—YWHAZ—epilepsy syndrome	9.26e-06	5.03e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NGF—epilepsy syndrome	9.16e-06	4.98e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.15e-06	4.97e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	8.96e-06	4.87e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.92e-06	4.85e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	8.91e-06	4.84e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—S100B—epilepsy syndrome	8.84e-06	4.8e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SOCS3—epilepsy syndrome	8.75e-06	4.76e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDC42—epilepsy syndrome	8.73e-06	4.75e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	8.72e-06	4.74e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—epilepsy syndrome	8.65e-06	4.7e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—epilepsy syndrome	8.65e-06	4.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	8.45e-06	4.59e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	8.39e-06	4.56e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	8.39e-06	4.56e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	8.28e-06	4.5e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	8.27e-06	4.5e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	8.11e-06	4.41e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	8.01e-06	4.35e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	8e-06	4.35e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	7.94e-06	4.32e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.82e-06	4.25e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	7.8e-06	4.24e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	7.77e-06	4.23e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	7.76e-06	4.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	7.75e-06	4.21e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	7.73e-06	4.2e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.7e-06	4.18e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.66e-06	4.16e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	7.65e-06	4.15e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	7.61e-06	4.14e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	7.47e-06	4.06e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	7.39e-06	4.02e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	7.19e-06	3.91e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	7.04e-06	3.82e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.02e-06	3.82e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	7e-06	3.8e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	6.96e-06	3.78e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	6.84e-06	3.72e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	6.81e-06	3.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	6.68e-06	3.63e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	6.68e-06	3.63e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	6.67e-06	3.62e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	6.66e-06	3.62e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	6.64e-06	3.61e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	6.63e-06	3.6e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.58e-06	3.58e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	6.54e-06	3.55e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	6.41e-06	3.48e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	6.33e-06	3.44e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	6.26e-06	3.4e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TH—epilepsy syndrome	6.24e-06	3.39e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	6.17e-06	3.35e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	6.16e-06	3.35e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	6.14e-06	3.34e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.14e-06	3.34e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6e-06	3.26e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	5.98e-06	3.25e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	5.72e-06	3.11e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	5.69e-06	3.09e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	5.67e-06	3.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	5.62e-06	3.05e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	5.61e-06	3.05e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	5.5e-06	2.99e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	5.41e-06	2.94e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	5.35e-06	2.91e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TH—epilepsy syndrome	5.33e-06	2.9e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.25e-06	2.85e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	5.21e-06	2.83e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.2e-06	2.83e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	5.16e-06	2.8e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAT—epilepsy syndrome	5.14e-06	2.79e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	5.01e-06	2.72e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	5e-06	2.72e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	4.97e-06	2.7e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	4.87e-06	2.65e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.73e-06	2.57e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	4.65e-06	2.53e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	4.61e-06	2.51e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	4.52e-06	2.46e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	4.49e-06	2.44e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	4.45e-06	2.42e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAT—epilepsy syndrome	4.39e-06	2.39e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.38e-06	2.38e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	4.27e-06	2.32e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	4.2e-06	2.28e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	4.16e-06	2.26e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGT—epilepsy syndrome	4.07e-06	2.21e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	4.04e-06	2.2e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.99e-06	2.17e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.97e-06	2.16e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.93e-06	2.14e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.81e-06	2.07e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	3.62e-06	1.97e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.53e-06	1.92e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGT—epilepsy syndrome	3.48e-06	1.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—POMC—epilepsy syndrome	3.43e-06	1.86e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—epilepsy syndrome	3.41e-06	1.85e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.13e-06	1.7e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.93e-06	1.59e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.79e-06	1.52e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.74e-06	1.49e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.67e-06	1.45e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.34e-06	1.27e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	2.25e-06	1.22e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.37e-06	7.47e-06	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.17e-06	6.38e-06	CbGpPWpGaD
